Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jun 27;14:130. doi: 10.1186/s12974-017-0905-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 2 — Effect of ALF-186 treatment on the expression of soluble guanylyl cyclase (sGC) β₁. a Representative western blot image (n = 8) showing the increase of sGC β₁ compared to β-Actin after immediate ALF-186 postconditioning. Enucleation was performed either 24 or 48 h after IRI. b Densitometric analysis of n = 8 western blots for sGC β₁ after ALF-186 (data are mean ± SD; IRI vs. IRI + ALF-186 24 h, *** = p < 0.001 and IRI vs. IRI + ALF-186 48 h, ** = p < 0.01). c Representative western blot image and densitometric analysis of n = 8 Western Blots for sGC β₁ compared to β-Actin after ODQ inhibition and ALF-186, ODQ inhibition alone and ODQ-inhibition and iALF-186. Enucleation was performed 24 h after IRI. d Densitometric analysis of n = 8 Western Blots for sGC β₁ after ALF-186 in the presence of ODQ